产品中心 抗体 其他一抗

所有图片(1/1)

Mouse Anti-Human CD20 Antibody (2H7)

B-lymphocyte antigen CD20,Bp35,Leukocyte surface antigen Leu-16,MS4A1

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B0764
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    CD20
  • 分子别名

    B-lymphocyte antigen CD20, Bp35, Leukocyte surface antigen Leu-16, MS4A1
  • 细胞定位

    Cell membrane
  • Accession

    P11836
  • 克隆号

    2H7
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG2b,k
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein A
  • 浓度

    0.2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度
    FCM 1:2000
背景介绍
  • B-lymphocyte antigen CD20 or CD20 is expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity. CD20 is expressed on all stages of B cell development except the first and last; it is present from late pro-B cells through memory cells, but not on either early pro-B cells or plasma blasts and plasma cells. It is found on B-cell lymphomas, hairy cell leukemia, B-cell chronic lymphocytic leukemia, and melanoma cancer stem cells. Immunohistochemistry can be used to determine the presence of CD20 on cells in histological tissue sections. Because CD20 remains present on the cells of most B-cell neoplasms, and is absent on otherwise similar appearing T-cell neoplasms, it can be very useful in diagnosing conditions such as B-cell lymphomas and leukaemias.

  • 流式分析

    • Flow cytometric analysis of human PBMC (human peripheral blood mononuclear cell) labelling CD20 antibody at 1/2000 (0.01 μg) dilution (Right) compared with a Mouse monoclonal IgG isotype control (Left). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD19 - Alexa Fluor® 647 separately. Gated on total viable cells.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)